One Step, One Observation: Granules India Keeps U.S. Doors Open

Unknown Apr 02, 2026 750 Views

Granules India Ltd has announced the successful completion of a US FDA inspection at its Bonthapally manufacturing facility, concluding with just one Form 483 observation. The inspection, which focused on Current Good Manufacturing Practices (cGMP), was conducted as part of the routine regulatory...